Search

everythinglearnresearchcommunity

for

Search:↓

PCOS can harm heart health by increasing risks like high blood pressure and diabetes, but treatments like birth control and lifestyle changes can help.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

People with depression often have higher hair cortisol levels, while those with PTSD tend to have lower levels, but more research is needed to understand this fully.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

Combining light therapy and microneedling shows promise for treating female hair loss.

The document covers various dermatological treatments and conditions.

Finasterid 1mg, used for male hair loss, can cause sexual problems in some men, which can last for several months even after stopping the medication.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Blue light can help treat skin conditions like eczema and acne without major side effects.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Two-photon microscopy effectively tracks live stem cell activity in mouse skin with minimal harm and clear images.

Hair protein analysis could improve medical testing and understanding of hair characteristics.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

New regenerative therapies show promise for treating hair loss.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Treating cystoid macular oedema in uveitis is difficult and risky.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

PRP therapy increases hair density for androgenetic alopecia.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.